Merck & Co., Inc.

NYSE: MRK
$80.72
+$1.68 (+2.1%)
Closing price May 29, 2020
24/7 Wall St. has put together a preview of Disney, Ford, Merck, Uber and some of the other most anticipated earnings reports that are expected this week.
Chris Lange
The January 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Chris Lange
The December 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Chris Lange
Here is a review and preview of how the model for Dow Jones industrial average could point to a baseline expectation of more than 7% gains in 2020.
Jon C. Ogg
Ahead of election years, the cost and future of health care has become one of the top debates for better than two decades now. Most politicians say that they want to lower prescription drug costs....
Jon C. Ogg
Here, 24/7 Wall St. presents a calendar of a few of the biggest clinical trial and FDA updates to watch for in early 2020.
Chris Lange
The December 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Chris Lange
Here, 24/7 Wall St. has included a calendar of a few of the biggest clinical trial and FDA updates to watch for going into 2020.
Chris Lange
NewLink Genetics and Merck shares made handy gains on Friday after it was announced that the FDA has granted approval to Ervebo, the Zaire Ebola virus vaccine V920.
Chris Lange
One theme that investors love in good times and in bad is dividend investing. One strategy that has been around for years is known as the Dogs of the Dow.
Jon C. Ogg
The November 29 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Chris Lange
As of the most recently reported period, short sellers favored Apple, Microsoft and Intel above all other Dow stocks.
Trey Thoelcke
Monday was a breakout day for a few biotech companies. Some made absolutely massive runs, practically doubling and then some. The biotechnology sector is pushing near all-time highs, and a few of...
Chris Lange
The November 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Chris Lange
Despite the never-ending election cycle, there actually is a clear path for the Dow to hit 30,000 as soon as early 2020, if only a few things come to fruition. There does not even have to be a big...
Jon C. Ogg